Skip to main content
Clinical Trials/JPRN-UMIN000008727
JPRN-UMIN000008727Completed未知

Effect of febuxostat on serum uric acid and renal function in patients with hyperuricemia. -open label, active (allopurinol)-controlled clinical study- - Effect of febuxostat on serum uric acid and renal function

Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine0 sites100 target enrollmentStarted: September 1, 2012Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Completed
Sponsor
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional

Eligibility Criteria

Ages
20years-old to ot applicable (—)
Sex
All

Inclusion Criteria

  • Not provided

Exclusion Criteria

  • (1)Febuxostat sensitivity (2)Hemodialysis patients (3)Secondary hyperuricemia (4)SBP>=160 or DBP>=100 (5)AST and ALT levels less than 2-times the upper limit of normal (6)Newly onset CAD and CVD within 6 months (7)Treated with mercaptopurine and azathioprine (8)During breast-feeding (9)Doctor considers inappropriate as subjects

Investigators

Sponsor
Division of Nephrology, Department of Internal Medicine, Juntendo University Faculty of Medicine

Similar Trials